What Researchers Did
Researchers conducted a MEDLINE search to review the impact of anaemia and tumour hypoxemia on cancer patients' quality of life and survival, and to assess problems associated with correction methods.
What They Found
Approximately 40-64% of cancer patients undergoing therapy are anaemic, a rate that increases with chemotherapy, radiotherapy, and hormonal therapy. Anaemia is linked to reduced quality of life and decreased survival, with tumour hypoxemia potentially contributing to tumour growth and treatment resistance.
What This Means for Canadian Patients
Canadian patients undergoing cancer treatment should discuss symptoms of anaemia, such as fatigue or shortness of breath, with their oncology team. Addressing anaemia can potentially improve their quality of life and response to cancer treatments.
Canadian Relevance
This study has no specific Canadian connection.
Study Limitations
As a review, this study's findings are dependent on the scope and quality of the existing literature included in the MEDLINE search.